Image by CDC

Cell & Gene Therapies

TIA brings together five key national cell and gene therapy development and manufacturing facilities (shown in the map below) to facilitate the translation from discovery to clinical benefit. Our consortium of CGT facilities has far reaching expertise to support and assist your development across the spectrum of cell and gene therapies regardless of your stage of development.

​

CGT.png

Available expertise

Science Lab

CROSSING THE VALLEY OF DEATH : Guidance for Researchers Translating a Research Discovery into an Advanced Therapeutic Product

TIA has produced a guidance document to assist you in translating your research discovery into an advanced therapeutic product.

Key messages:

  • It is never too early to reach out to the facilities within TIA’s Cell & Gene Therapy Capability for advice on making the transition from research to development.

 

  • Early engagement with TIA or one of the facilities will enable you to leverage their significant expertise and expedite your translation to clinical development.

 

  • Understanding GMP requirements early will save you time and money.

0001.jpg
Do you have a technical problem or a research need? Reach out to us by completing the enquiry form and we will endeavour to find you the right connection. 

Contact us